
Annapoorna S Kini MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Associate Professor, Medicine, Icahn School of Medicine
Request Appointment
5 E 98th St3RD floorNew York, NY 10029
Fax+1 212-534-2845
Overview of Dr. Kini
Dr. Annapoorna Kini is a cardiologist in New York, NY. She received her medical degree from Kasturba Medical College Manipal and has been in practice 34 years. She has more than 100 publications and over 500 citings.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1999 - 2002
- Westchester Medical CenterResidency, Internal Medicine, 1997 - 1999
- Kasturba Medical College ManipalClass of 1991
Certifications & Licensure
- NY State Medical License 2002 - 2025
- NY State Medical License 2006 - 2025
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- IVUS Improves Outcomes With SUPERA Stents for the Treatment of Superficial Femoral-Popliteal Artery Disease.Prakash Krishnan, Raman Sharma, Sriya Avadhani, Arthur Tarricone, Allen Gee
Journal of Endovascular Therapy. 2025-04-01 - 2 citations1-Year Real-World Outcomes of TAVR With the Fifth-Generation Balloon-Expandable Valve in the United States.Annapoorna S Kini, Gilbert H L Tang, Ricardo Yaryura, George Petrossian, David K Roberts
JACC. Cardiovascular Interventions. 2025-03-24 - Clinical outcomes after complex and high-risk percutaneous coronary intervention according to baseline chronic kidney disease.Francesca Maria Di Muro, Samantha Sartori, Birgit Vogel, Yihan Feng, Mauro Gitto
Clinical Research in Cardiology. 2025-02-25
Authored Content
- Considerations for Optimal Device Selection in Transcatheter Aortic Valve ReplacementSeptember 2020
Press Mentions
- Women Most Vulnerable to Heart Disease Risk Factors, Study ShowsApril 1st, 2025
- Better 1-Year Echo and Clinical Outcomes with New Sapien Ultra ResiliaNovember 26th, 2024
- Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW IIINovember 21st, 2024
- Join now to see all